HealthMap_150x.90_1200.jpg
Howard Shaps, MD, MBA, Named Chief Clinical Officer at Healthmap Solutions
June 15, 2021 09:05 ET | Healthmap Solutions
TAMPA, Fla., June 15, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an industry leading NCQA accredited kidney population health management company, today announced the appointment...
22157.jpg
Diabetic Nephropathy Disease Analysis Report 2021: Overall Likelihood of Approval of a Phase I DN Asset is 4%, and the Average Probability a Drug Advances from Phase III is 33.3%
March 23, 2021 08:13 ET | Research and Markets
Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering. Diabetic nephropathy, also known as diabetic...
HealthMap_150x.90_1200.jpg
Healthmap Solutions Urges Medicare Advantage Plans to Act Now In Advance of 21st Century Cures Act Implementation
July 22, 2020 09:00 ET | Healthmap Solutions
TAMPA, Fla., July 22, 2020 (GLOBE NEWSWIRE) -- Healthmap Solutions, a rapidly growing specialty Population Health Management (PHM) company with a flagship Kidney Health Management (KHM) program,...
HealthMap_150x.90_1200.jpg
Regence and Healthmap Solutions partner to provide Kidney Health Management program to members
June 11, 2020 09:00 ET | Healthmap Solutions
PORTLAND, Ore., June 11, 2020 (GLOBE NEWSWIRE) -- Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd
June 15, 2016 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients...
Rockwell Medical, Inc. logo
Rockwell Medical Enters Into Exclusive License Agreement With Wanbang Biopharmaceutical Co., Ltd. to Commercialize Triferic® in China
February 16, 2016 08:00 ET | Rockwell Medical, Inc.
WIXOM, Mich., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Pricing of Initial Public Offering
October 21, 2014 19:36 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc., a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and...